149 related articles for article (PubMed ID: 37925396)
21. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
22. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
23. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler
Tamási L; Szilasi M; Gálffy G
Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
Zyryanov SK; Dyakov IN; Aisanov ZR
Ter Arkh; 2022 Aug; 94(7):850-858. PubMed ID: 36286942
[TBL] [Abstract][Full Text] [Related]
25. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
[TBL] [Abstract][Full Text] [Related]
26. Availability, affordability and price components of insulin products in different-level hospital pharmacies: Evidence from two cross-sectional surveys in Nanjing, China.
Wang L; Dai L; Liu H; Dai H; Li X; Ge W
PLoS One; 2021; 16(8):e0255742. PubMed ID: 34383816
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.
Bibi M; Haq NU; Kareem A; Ullah H; Baloch N; Rehman G; Nasim A
Int J Public Health; 2022; 67():1604375. PubMed ID: 35872706
[No Abstract] [Full Text] [Related]
28. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
29. Anti-hypertensive medication access and affordability and their association with blood pressure control at a teaching hospital in Ghana.
Harrison MA; Marfo AFA; Opare-Addo MNA; Ankrah DNA; Acheampong F; Nelson F; Buabeng KO
Pan Afr Med J; 2021; 39():184. PubMed ID: 34584609
[TBL] [Abstract][Full Text] [Related]
30. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
Dabare PR; Wanigatunge CA; Beneragama BH
BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
[TBL] [Abstract][Full Text] [Related]
31. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
[No Abstract] [Full Text] [Related]
32. Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study.
Stolbrink M; Ozoh OB; Halpin DMG; Nightingale R; Meghji J; Plum C; Allwood BW; Jayasooriya S; Mortimer K;
Thorax; 2024 Jun; 79(7):676-679. PubMed ID: 38760170
[TBL] [Abstract][Full Text] [Related]
33. Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey.
Mohammed SA; Tsehay T; Faris AG; Mengstu G
PLoS One; 2022; 17(12):e0279465. PubMed ID: 36542641
[TBL] [Abstract][Full Text] [Related]
34. Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings.
Siddharthan T; Robertson NM; Rykiel NA; Underhill LJ; Rahman N; Kafle S; Mohan S; Padalkar R; McKeown S; Flores-Flores O; Quaderi SA; Alupo P; Kalyesubula R; Kirenga B; Luo J; Cárdenas MK; Gianella G; Miranda JJ; Checkley W; Hurst JR; Pollard SL
PLOS Glob Public Health; 2022; 2(12):e0001309. PubMed ID: 36962898
[TBL] [Abstract][Full Text] [Related]
35. Accessibility of Essential Medicines for Children in Sichuan Province of China: A Cross-Sectional Study.
Chen Z; Li S; Choonara I; Zeng L; Jia ZJ; Cheng G; Yu Q; Zhang L
Front Pharmacol; 2022; 13():828152. PubMed ID: 35250577
[No Abstract] [Full Text] [Related]
36. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
37. The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries.
Babar ZU; Ramzan S; El-Dahiyat F; Tachmazidis I; Adebisi A; Hasan SS
Front Pharmacol; 2019; 10():1375. PubMed ID: 31824316
[No Abstract] [Full Text] [Related]
38. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
[TBL] [Abstract][Full Text] [Related]
39. Improving access to medicines by popularising generics: a study of 'India's People's Medicine' scheme in two districts of Maharashtra.
Lavtepatil S; Ghosh S
BMC Health Serv Res; 2022 May; 22(1):643. PubMed ID: 35562697
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
